Blueberries Medical Corp. (BBM.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.22 Million CAD | 16.99% |
| 2022 | -1.65 Million CAD | 12.0% |
| 2021 | -1.88 Million CAD | 55.18% |
| 2020 | -4.2 Million CAD | 61.13% |
| 2019 | -10.81 Million CAD | -568.98% |
| 2018 | -1.61 Million CAD | -2831.28% |
| 2017 | -55.15 Thousand CAD | 86.67% |
| 2016 | -413.72 Thousand CAD | -212.0% |
| 2015 | -132.6 Thousand CAD | -45.42% |
| 2014 | -91.18 Thousand CAD | 61.19% |
| 2013 | -234.97 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -254.5 Thousand CAD | 35.93% |
| 2024 Q2 | -246.14 Thousand CAD | 3.28% |
| 2023 Q3 | -380.95 Thousand CAD | -19.84% |
| 2023 FY | -1.37 Million CAD | 16.99% |
| 2023 Q4 | -397.21 Thousand CAD | -4.27% |
| 2023 Q1 | -323.76 Thousand CAD | -17.93% |
| 2023 Q2 | -317.88 Thousand CAD | 1.81% |
| 2022 FY | -1.65 Million CAD | 12.0% |
| 2022 Q4 | -274.53 Thousand CAD | 43.45% |
| 2022 Q3 | -485.51 Thousand CAD | -1.81% |
| 2022 Q2 | -476.86 Thousand CAD | 14.12% |
| 2022 Q1 | -555.24 Thousand CAD | 33.05% |
| 2021 Q1 | -492.57 Thousand CAD | 43.13% |
| 2021 FY | -1.88 Million CAD | 55.18% |
| 2021 Q2 | -212.22 Thousand CAD | 56.91% |
| 2021 Q3 | -350.11 Thousand CAD | -64.97% |
| 2021 Q4 | -829.28 Thousand CAD | -136.86% |
| 2020 Q3 | -944.43 Thousand CAD | -7.53% |
| 2020 FY | -4.2 Million CAD | 61.13% |
| 2020 Q4 | -866.1 Thousand CAD | 8.29% |
| 2020 Q1 | -1.37 Million CAD | 13.8% |
| 2020 Q2 | -878.31 Thousand CAD | 36.14% |
| 2019 Q1 | -5.09 Million CAD | -67123.09% |
| 2019 FY | -10.81 Million CAD | -568.98% |
| 2019 Q4 | -1.59 Million CAD | 27.52% |
| 2019 Q3 | -2.2 Million CAD | -33.76% |
| 2019 Q2 | -1.64 Million CAD | 67.7% |
| 2018 Q1 | -7692.00 CAD | 71.2% |
| 2018 FY | -1.61 Million CAD | -2831.28% |
| 2018 Q4 | -7580.00 CAD | 68.5% |
| 2018 Q3 | -24.06 Thousand CAD | -26.79% |
| 2018 Q2 | -18.98 Thousand CAD | -146.75% |
| 2017 Q2 | -14.12 Thousand CAD | 95.59% |
| 2017 Q1 | -319.88 Thousand CAD | -675.1% |
| 2017 FY | -55.15 Thousand CAD | 86.67% |
| 2017 Q4 | -26.71 Thousand CAD | -302.84% |
| 2017 Q3 | -6631.00 CAD | 53.04% |
| 2016 Q3 | -367.75 Thousand CAD | -1382.16% |
| 2016 Q2 | -24.81 Thousand CAD | 14.19% |
| 2016 Q1 | -28.91 Thousand CAD | 12.98% |
| 2016 FY | -413.72 Thousand CAD | -212.0% |
| 2016 Q4 | -41.27 Thousand CAD | 88.78% |
| 2015 Q1 | -25.25 Thousand CAD | -7.89% |
| 2015 FY | -132.6 Thousand CAD | -45.42% |
| 2015 Q3 | -44.84 Thousand CAD | -75.06% |
| 2015 Q4 | -33.23 Thousand CAD | 25.89% |
| 2015 Q2 | -25.61 Thousand CAD | -1.41% |
| 2014 Q4 | -23.41 Thousand CAD | 11.73% |
| 2014 Q3 | -26.52 Thousand CAD | -65.88% |
| 2014 FY | -91.18 Thousand CAD | 61.19% |
| 2014 Q2 | -15.98 Thousand CAD | 81.72% |
| 2014 Q1 | -87.47 Thousand CAD | -900.24% |
| 2013 Q4 | -8745.00 CAD | -524.64% |
| 2013 Q2 | -109.78 Thousand CAD | 0.0% |
| 2013 FY | -234.97 Thousand CAD | 0.0% |
| 2013 Q3 | -1400.00 CAD | 98.72% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -1.19 Million CAD | -2.991% |
| Ayurcann Holdings Corp. | -3.25 Million CAD | 62.27% |
| The BC Bud Corporation | -1.22 Million CAD | -0.253% |
| BioNxt Solutions Inc. | -6.36 Million CAD | 80.736% |
| CordovaCann Corp. | -2.51 Million CAD | 51.182% |
| Christina Lake Cannabis Corp. | -880.54 Thousand CAD | -39.296% |
| Captor Capital Corp. | 655.2 Thousand CAD | 287.203% |
| City View Green Holdings Inc. | -996.45 Thousand CAD | -23.094% |
| 1CM Inc. | 300.79 Thousand CAD | 507.781% |
| Global Hemp Group Inc. | -551.7 Thousand CAD | -122.322% |
| Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 68.38% |
| IM Cannabis Corp. | -12.17 Million CAD | 89.926% |
| Lobe Sciences Ltd. | -3.35 Million CAD | 63.488% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -212.728% |
| Mountain Valley MD Holdings Inc. | -3.18 Million CAD | 61.501% |
| Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 326.192% |
| Ovation Science Inc. | -764 Thousand CAD | -60.544% |
| Pharmadrug Inc. | -1.33 Million CAD | 8.123% |
| Captiva Verde Wellness Corp. | -1.14 Million CAD | -7.408% |
| RAMM Pharma Corp. | -7.08 Million CAD | 82.691% |
| RIV Capital Inc. | 1.78 Million CAD | 168.899% |
| Revive Therapeutics Ltd. | -3.28 Million CAD | 62.673% |
| Red White & Bloom Brands Inc. | -8.76 Million CAD | 86.013% |
| SLANG Worldwide Inc. | -5.98 Million CAD | 79.511% |
| 1933 Industries Inc. | -9.34 Million CAD | 86.881% |
| Red Light Holland Corp. | -6.44 Million CAD | 80.973% |
| Top Strike Resources Corp. | -784.8 Thousand CAD | -56.29% |
| Xebra Brands Ltd. | -1.55 Million CAD | 21.097% |
| Adastra Holdings Ltd. | -1.79 Million CAD | 31.62% |